retatrutide clinical trial ESC 2024: improves lipid and cardiovascular risk profile in Phase II A Study of Retatrutide (LY3437943)

Wu L, Zhou M, Li T, et al

For your safety, your surgery may need to be delayed by a few hours to allow your stomach to empty

Hdersdal S, Lund A, Knop FK, Vilsbll T

The American Diabetes Association recommends regular blood glucose monitoring and potential adjustment of insulin or sulfonylurea doses when starting semaglutide to prevent hypoglycemia

HSA and FSA accounts remain eligible for PlexusDx medications, allowing you to use pre-tax health savings if you have these accounts available

For example, the SELECT trial reported that semaglutide reduced the risk of MACE by 20% (Hazard Ratio (HR) 0.80, 95% confidence interval (CI) 0.720.90) in people with obesity but without diabetes, although several secondary outcomes did not reach statistical significance under hierarchical testing procedures